Therapeutic compositions, devices and methods for observing treated tissues

A method for diagnosing damaged or diseased tissue biomarkers utilizing a birefringence light detecting device comprising:

• a polarizing light probe for subjecting a tissue sample to polarizing light such that the tissue biomarkers are observable as emitted birefringence luminescence signals;
• a fiber optic cable operably connected to the polarizing light probe for transmitting the birefringence luminescence signals emitted by the tissue sample;
• and
• a digital display device operably connected to the polarizing fiber optic cable for receiving and displaying the birefringence luminescence signals transmitted by the polarizing fiber optic cable,
• wherein said method comprises,
• directing the polarizing light at a tissue to be examined;
• transmitting birefringence luminescence signals via the fiber optic cable to the digital display device;
• observing one or more tissue biomarkers made visible by the birefringence luminescence signal on the digital display device;
• analyzing the tissue biomarkers for indications of disease or damage to the tissue.

A synthetic biopharmaceutical anti-inflammatory immunotherapeutic agent composition having components equivalent to human tissue, comprising:

• (i) a plurality of the 20 alpha amino acids (9 essential, 11 nonessential) specified by the genetic code of human and mammalian tissue wherein no more than 10% of the amino acids are in D-form;
• (ii) at least one of the 24 elements indicated in the periodic table as components of human and mammalian tissue;
• (iii) at least one extracellular matrix compound in an amount effective in the damaged tissue as anti-inflammatory and anti-neoangiogenetic agent, wherein said extracellular matrix compound is selected from the group consisting of a glycosaminoglycan, a collagen, cartilage, chondroitin sulfate, heparan sulfate, dermatan sulfate, hyaluronic acid, a glycoprotein, and a proteoglycan;
• (iv) at least one polar surface active lipid, wherein said polar surface active lipid is selected from the group consisting of a phospholipid, a glycolipid and a lipoprotein.